Streptomyces argillaceus Routien (ATCC® 12956)

Strain Designations: 5576-27  /  Type Strain: no  /  Biosafety Level: 1

Permits And Restrictions

View Permits

Strain Designations 5576-27
Produces plicamycin mithramycin
Production of the tumor-inhibiting agents mithramycin A, B and/or C
Type Strain no
Biosafety Level 1
Product Format freeze-dried
Preceptrol® no
Type Strain no
Medium ATCC® Medium 196: Yeast malt extract agar
Growth Conditions
Temperature: 26.0°C
Name of Depositor Chas. Pfizer & Co., Inc.

Sobin BA, et al. Mithramycins as transplanted tumor inhibiting agents. US Patent 3,646,194 dated Feb 29 1972

Cross References

Nucleotide (GenBank) : Y10907 S.argillaceus mtmD and mtmE genes.

Nucleotide (GenBank) : AJ007932 Streptomyces argillaceus mithramycin biosynthetic genes.

Nucleotide (GenBank) : X89899 S.argillaceus DNA for mtmQ, mtmX, mtmP, mtmK, mtmS and mtmT1 genes.

Nucleotide (GenBank) : AF056309 Streptomyces argillaceus membrane protein and mithramycin regulator MtmR (mtmR) genes, complete cds.

Nucleotide (GenBank) : AF056310 Streptomyces argillaceus sequence similar to the region upstream of the mithramycin regulatory gene.

Nucleotide (GenBank) : U43537 Streptomyces argillaceus mithramycin resistance determinant, ATP-binding protein (mtrA) and membrane protein (mtrB) genes, complete cds.

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation